================================================================================
     HCT SURVIVAL PREDICTION - CASOS PARA DEMO
     Fecha: 13 de Diciembre, 2025
================================================================================

Instrucciones: Ingresar estos pacientes manualmente durante la demo para
demostrar el funcionamiento del sistema de predicci√≥n.

================================================================================
CASO 1: RIESGO BAJO (esperado ~7-8%)
================================================================================
Nombre: James Thompson

TAB 1 - Demographics:
- Age at HCT: 28
- Sex: Male
- Race: White
- Ethnicity: Non-Hispanic

TAB 2 - Disease Information:
- Primary Disease: AML
- Disease Status at HCT: CR1 (First Complete Remission)
- Disease Risk Index: Low
- Time from Diagnosis to HCT (months): 4

TAB 3 - Transplant Details:
- Conditioning Intensity: Myeloablative
- Graft Type: Peripheral Blood
- TBI Used: No
- Year of HCT: 2024

TAB 4 - Donor Information:
- Donor Type: Related
- Donor Age: 30
- Donor-Recipient Sex Match: Male-Male
- HLA Match: 10/10
- ABO Compatibility: Compatible
- CMV Status (Donor): Negative
- CMV Status (Patient): Negative

TAB 5 - Clinical Status:
- Karnofsky Score: 90
- HCT-CI Score: 0
- Prior Autologous HCT: No
- Prior Allogeneic HCT: No

TAB 6 - Laboratory Values:
- Albumin (g/dL): 4.2
- Bilirubin (mg/dL): 0.8
- Creatinine (mg/dL): 0.9
- WBC at Diagnosis: 12000
- Platelets at HCT: 180000
- Hemoglobin at HCT: 13.5
- Ferritin: 350

TAB 7 - Additional Factors:
- GVHD Prophylaxis: Tacrolimus + MTX
- ATG/Alemtuzumab Used: No
- Infection History: None
- Comorbidities: None

================================================================================
CASO 2: RIESGO BAJO (esperado ~21%)
================================================================================
Nombre: Sarah Johnson

TAB 1 - Demographics:
- Age at HCT: 35
- Sex: Female
- Race: White
- Ethnicity: Non-Hispanic

TAB 2 - Disease Information:
- Primary Disease: ALL
- Disease Status at HCT: CR1 (First Complete Remission)
- Disease Risk Index: Low
- Time from Diagnosis to HCT (months): 6

TAB 3 - Transplant Details:
- Conditioning Intensity: Myeloablative
- Graft Type: Bone Marrow
- TBI Used: Yes
- Year of HCT: 2024

TAB 4 - Donor Information:
- Donor Type: Related
- Donor Age: 38
- Donor-Recipient Sex Match: Male-Female
- HLA Match: 10/10
- ABO Compatibility: Compatible
- CMV Status (Donor): Negative
- CMV Status (Patient): Negative

TAB 5 - Clinical Status:
- Karnofsky Score: 90
- HCT-CI Score: 1
- Prior Autologous HCT: No
- Prior Allogeneic HCT: No

TAB 6 - Laboratory Values:
- Albumin (g/dL): 4.0
- Bilirubin (mg/dL): 0.9
- Creatinine (mg/dL): 0.8
- WBC at Diagnosis: 15000
- Platelets at HCT: 165000
- Hemoglobin at HCT: 12.2
- Ferritin: 420

TAB 7 - Additional Factors:
- GVHD Prophylaxis: Tacrolimus + MTX
- ATG/Alemtuzumab Used: No
- Infection History: None
- Comorbidities: Mild Cardiac

================================================================================
CASO 3: RIESGO MEDIO (esperado ~53%)
================================================================================
Nombre: Jennifer Brown

TAB 1 - Demographics:
- Age at HCT: 55
- Sex: Female
- Race: Black/African American
- Ethnicity: Non-Hispanic

TAB 2 - Disease Information:
- Primary Disease: MDS
- Disease Status at HCT: Advanced
- Disease Risk Index: Intermediate
- Time from Diagnosis to HCT (months): 8

TAB 3 - Transplant Details:
- Conditioning Intensity: Reduced Intensity
- Graft Type: Peripheral Blood
- TBI Used: No
- Year of HCT: 2023

TAB 4 - Donor Information:
- Donor Type: Unrelated
- Donor Age: 28
- Donor-Recipient Sex Match: Male-Female
- HLA Match: 9/10
- ABO Compatibility: Minor Incompatible
- CMV Status (Donor): Positive
- CMV Status (Patient): Positive

TAB 5 - Clinical Status:
- Karnofsky Score: 80
- HCT-CI Score: 3
- Prior Autologous HCT: No
- Prior Allogeneic HCT: No

TAB 6 - Laboratory Values:
- Albumin (g/dL): 3.5
- Bilirubin (mg/dL): 1.2
- Creatinine (mg/dL): 1.1
- WBC at Diagnosis: 3500
- Platelets at HCT: 85000
- Hemoglobin at HCT: 9.8
- Ferritin: 1200

TAB 7 - Additional Factors:
- GVHD Prophylaxis: Tacrolimus + MMF
- ATG/Alemtuzumab Used: Yes
- Infection History: Prior Fungal
- Comorbidities: Diabetes

================================================================================
CASO 4: RIESGO ALTO (esperado ~95%)
================================================================================
Nombre: Robert Martinez

TAB 1 - Demographics:
- Age at HCT: 62
- Sex: Male
- Race: White
- Ethnicity: Hispanic

TAB 2 - Disease Information:
- Primary Disease: AML
- Disease Status at HCT: Relapse
- Disease Risk Index: High
- Time from Diagnosis to HCT (months): 18

TAB 3 - Transplant Details:
- Conditioning Intensity: Reduced Intensity
- Graft Type: Peripheral Blood
- TBI Used: No
- Year of HCT: 2023

TAB 4 - Donor Information:
- Donor Type: Haploidentical
- Donor Age: 35
- Donor-Recipient Sex Match: Female-Male
- HLA Match: 5/10
- ABO Compatibility: Major Incompatible
- CMV Status (Donor): Positive
- CMV Status (Patient): Positive

TAB 5 - Clinical Status:
- Karnofsky Score: 60
- HCT-CI Score: 5
- Prior Autologous HCT: Yes
- Prior Allogeneic HCT: No

TAB 6 - Laboratory Values:
- Albumin (g/dL): 2.9
- Bilirubin (mg/dL): 2.1
- Creatinine (mg/dL): 1.6
- WBC at Diagnosis: 85000
- Platelets at HCT: 45000
- Hemoglobin at HCT: 8.2
- Ferritin: 2800

TAB 7 - Additional Factors:
- GVHD Prophylaxis: Post-Cy + Tacrolimus
- ATG/Alemtuzumab Used: No
- Infection History: Prior Bacterial, Prior Viral
- Comorbidities: Cardiac, Pulmonary, Renal

================================================================================
CASO 5: RIESGO ALTO (esperado ~100%)
================================================================================
Nombre: Ahmed Hassan

TAB 1 - Demographics:
- Age at HCT: 68
- Sex: Male
- Race: Other
- Ethnicity: Non-Hispanic

TAB 2 - Disease Information:
- Primary Disease: AML
- Disease Status at HCT: Primary Induction Failure
- Disease Risk Index: Very High
- Time from Diagnosis to HCT (months): 24

TAB 3 - Transplant Details:
- Conditioning Intensity: Reduced Intensity
- Graft Type: Peripheral Blood
- TBI Used: No
- Year of HCT: 2022

TAB 4 - Donor Information:
- Donor Type: Unrelated
- Donor Age: 45
- Donor-Recipient Sex Match: Female-Male
- HLA Match: 8/10
- ABO Compatibility: Major Incompatible
- CMV Status (Donor): Positive
- CMV Status (Patient): Positive

TAB 5 - Clinical Status:
- Karnofsky Score: 50
- HCT-CI Score: 6
- Prior Autologous HCT: No
- Prior Allogeneic HCT: Yes

TAB 6 - Laboratory Values:
- Albumin (g/dL): 2.5
- Bilirubin (mg/dL): 2.8
- Creatinine (mg/dL): 1.9
- WBC at Diagnosis: 120000
- Platelets at HCT: 25000
- Hemoglobin at HCT: 7.5
- Ferritin: 4500

TAB 7 - Additional Factors:
- GVHD Prophylaxis: Tacrolimus + MTX
- ATG/Alemtuzumab Used: Yes
- Infection History: Prior Bacterial, Prior Viral, Prior Fungal
- Comorbidities: Cardiac, Pulmonary, Hepatic, Renal

================================================================================
CASO 6: RIESGO ALTO (esperado ~100%)
================================================================================
Nombre: William Anderson

TAB 1 - Demographics:
- Age at HCT: 72
- Sex: Male
- Race: White
- Ethnicity: Non-Hispanic

TAB 2 - Disease Information:
- Primary Disease: MDS
- Disease Status at HCT: Advanced/Transformed
- Disease Risk Index: Very High
- Time from Diagnosis to HCT (months): 36

TAB 3 - Transplant Details:
- Conditioning Intensity: Reduced Intensity
- Graft Type: Peripheral Blood
- TBI Used: No
- Year of HCT: 2022

TAB 4 - Donor Information:
- Donor Type: Unrelated
- Donor Age: 55
- Donor-Recipient Sex Match: Female-Male
- HLA Match: 7/10
- ABO Compatibility: Major Incompatible
- CMV Status (Donor): Positive
- CMV Status (Patient): Positive

TAB 5 - Clinical Status:
- Karnofsky Score: 50
- HCT-CI Score: 7
- Prior Autologous HCT: No
- Prior Allogeneic HCT: Yes

TAB 6 - Laboratory Values:
- Albumin (g/dL): 2.3
- Bilirubin (mg/dL): 3.2
- Creatinine (mg/dL): 2.1
- WBC at Diagnosis: 2000
- Platelets at HCT: 18000
- Hemoglobin at HCT: 7.0
- Ferritin: 5200

TAB 7 - Additional Factors:
- GVHD Prophylaxis: Tacrolimus + MMF
- ATG/Alemtuzumab Used: Yes
- Infection History: Prior Bacterial, Prior Viral, Prior Fungal
- Comorbidities: Cardiac, Pulmonary, Hepatic, Renal, Diabetes

================================================================================
     FIN DE CASOS PARA DEMO
================================================================================
